State of Wisconsin Investment Board
CADL icon

State of Wisconsin Investment Board’s Candel Therapeutics CADL Stock Holding History

State of Wisconsin Investment Board’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,147
Closed -$295K – 2514
2025
Q4 		$295K Sell
52,147
-1,900
-4% -$10.2K ﹤0.01% 2173
2025
Q3 		$276K Buy
+54,047
New +$312K ﹤0.01% 2146

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wisconsin Investment Board's CADL Position: Q1 2026 in Review

State of Wisconsin Investment Board sold out of Candel Therapeutics (CADL) in Q1 2026, closing a stake of 52,147 shares — an estimated $295K sold.

State of Wisconsin Investment Board first reported a position in CADL in Q3 2025 and held it in 2 quarters. The position peaked at $295K in Q4 2025. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • State of Wisconsin Investment Board reported no remaining Candel Therapeutics position as of Q1 2026 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 52,147 Candel Therapeutics shares in Q1 2026, an estimated $295K.
  • State of Wisconsin Investment Board first reported a position in Candel Therapeutics in Q3 2025 and held it in 2 quarters.
  • State of Wisconsin Investment Board's Candel Therapeutics position peaked at $295K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.